URO Urodynamix Technologies Ltd.

Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that the American
Medical Association (AMA) has published its 2010 Current Procedural Terminology
(CPT)(1) codes with additions, changes and deletions of billing codes for all
medical specialities including urology.


As of January 2010, CPT Code 51795, "Voiding pressure studies (VP); bladder
voiding pressure, any technique," will be discontinued and be replaced by a new
CPT Code 51728, "Complex cystometrogram (ie, calibrated electronic equipment);
with voiding pressure studies (ie, bladder voiding pressure), any technique" and
several other related codes. Urodynamix does not believe physicians can use the
new code to bill for the uroNIRS(TM) procedure once it is effective January 1,
2010, as the uroNIRS(TM) procedure does not include the performance of a complex
cystometrogram. Thus, physicians and other providers will need to use a
miscellaneous code to submit claims for uroNIRS(TM) or work with payors on other
coding alternatives. CPT codes are used to bill for physician procedures under
the Medicare Physician Fee Schedule in the United States. They also are used by
providers to submit claims to private payors.


"The discontinuation of the 51795 Code likely will have a negative impact on US
sales but will not affect sales of uroNIRS(TM) in international markets. We are
confident that uroNIRS's accuracy, value, cost effectiveness and ease of use
will be apparent and valuable to patients, payors and providers alike, and that
the Company can continue to build on its installed base," said Barry Allen,
President and Chief Executive Officer of Urodynamix Technologies Ltd. "We have
worked closely with the American Urological Association (AUA) to introduce the
NIRS technology and educate them on the value of the NIRS procedure and are
confident that this will ultimately result in unique codes for uroNIRS(TM)." The
Company currently is working with the AUA on potential coding options for
uroNIRS(TM) and anticipates that the issue will be discussed at the upcoming
February 11-13, 2010 meeting of the AMA's CPT Editorial Panel.


The Company will continue to market the device in the US during 2010 and will
work with providers and payors to support sales efforts and claims submission.


For further information about AMA CPT Codes please visit:
http://www.ama-assn.org and the American Urology Association at
http://www.auanet.org


(1) CPT(R) is a registered trademark of the AMA.

About Urodynamix Technologies Ltd.

Urodynamix Technologies is a Canadian medical device company developing and
commercializing non-invasive medical technology based on proprietary
applications of near-infrared spectroscopy (NIRS). The Company is currently
focused on products that aid in the diagnosis and treatment of urinary
incontinence, lower urinary tract symptoms, erectile dysfunction, prostate
cancer, benign prostatic hyperplasia, and traumatic increases in intra-abdominal
pressure that cause abdominal compartment syndrome. Urodynamix's breakthrough
medical technology has the potential to beneficially affect more than 200
million people worldwide. www.urodynamix.com


Certain information contained in this press release may be forward-looking and
is subject to unknown risks, which could cause actual results to differ
materially from those set forth or implied herein. Although the Company believes
that the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will prove correct.

Urodynamix Technologies Ltd. (TSXV:URO)
Historical Stock Chart
Von Jul 2024 bis Aug 2024

Urodynamix Technologies Ltd. (TSXV:URO)
Historical Stock Chart
Von Aug 2023 bis Aug 2024